ClinicalTrials.Veeva

Menu

Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis (DRIVEALS)

I

Istituto Auxologico Italiano

Status

Enrolling

Conditions

Motor Neuron Disease
Amyotrophic Lateral Sclerosis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this observational study is to understand the clinical variability in a population of ALS patients using multidimensional biomarkers. The main questions it aims to answer are:

  • Which set of biomarkers explain genotypic-phenotypic correlations in ALS?
  • Which set of biomarkers can be used to subdivide the ALS population in homogeneous subgroups?

Participants will undergo:

  • neurological evaluation
  • neurophysiological evaluation
  • neuropsychological evaluation
  • whole exome sequencing
  • biomarker measurement in CSF and plasma

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis of ALS or other motor neuron disease
  • residence near the study centers

Exclusion criteria

  • refusal to participate to the study
  • unable/unwilling to perform follow-up visits

Trial contacts and locations

3

Loading...

Central trial contact

Nicola Ticozzi, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems